Frances S. Kittrell

Publication List Details

Period

2004 - 2008

Number

8

Co-Authors

Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models (2008)

Abba, Martin C, Hu, Yuhui, Levy, Carla C, Gaddis, Sally, Kittrell, Frances S, Zhang, Yun, ...

Abstract Background The rexinoid bexarotene (LGD1069, Targretin) is a highly selective retinoid × receptor (RXR) agonist that inhibits the growth of pre-malignant and malignant breast cells....

Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models (2007)

Rajkumar, Lakshmanaswamy, Kittrell, Frances S, Guzman, Raphael C, Brown, Powel H, Nandi, Satyabrata, Medina, Daniel

Abstract Introduction The experiments reported here address the question of whether a short-term hormone treatment can prevent mammary tumorigenesis in two different genetically engineered mouse...

Osteopontinis a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine (2004)

Unni, Emmanual, Kittrell, Frances S, Singh, Uma, Sinha, Raghu

Abstract Background Se-methylselenocysteine (MSC) is a naturally occurring organoselenium compound that inhibits mammary tumorigenesis in laboratory animals and in cell culture models. Previously we...

Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice : A Model for Li-Fraumeni Syndrome

Kuperwasser, Charlotte, Hurlbut, Gregory D., Kittrell, Frances S., Dickinson, Ellen S., Laucirica, Rudy, Medina, Daniel, ...

Breast cancer is the most frequent tumor type among women in the United States and in individuals with Li-Fraumeni syndrome. The p53 tumor suppressor gene is altered in a large proportion of both...